Lupus treatment with stem cells is a high-tech medical approach that balances the immune system and supports damaged organs at the cellular level, with the aim of breaking the autoimmune cycle in which the body attacks its own tissues.
This treatment utilizes regenerative medicine methods to manage chronic inflammation and minimize the risk of organ failure, especially in patients with Systemic Lupus Erythematosus (SLE).
What is Lupus (Systemic Lupus Erythematosus)?
Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease where the immune system recognizes its own cells as a “threat” and attacks vital organs such as the joints, skin, kidneys, and heart.
At this point, stem cell therapy stands out as an innovative strategy used to “reset” the malfunctioning immune response or to calm overactive defense cells.
While traditional immunosuppressive drugs weaken the entire defense system, stem cell approaches aim to “train” and repair the system rather than suppress it.
Mechanism of Action of Stem Cells in Lupus Disease
After being introduced into the body, stem cells migrate to areas where inflammation is most intense and begin to emit special signaling molecules there.
Thanks to this mechanism, the production process of autoantibodies, which are overproduced in lupus patients and cause tissue damage, is controlled at the cellular level.
The cells also support damaged endothelial tissues (vessel lining) and organ parenchyma, helping to reverse systemic damage.
Reorganization of the Immune System (Immunomodulation)
Immunomodulation is the process by which stem cells give a “stop” command to immune cells and return them to their normal function.
Stem cells increase the number of T-regulatory cells, rebuilding the immune system’s tolerance to its own tissues.
This process relieves the “cytokine storm” that is common in lupus patients and reduces the frequency and severity of flare periods of the disease.
According to Assoc. Prof. Dr. Erdinç Özek: “Stem cell application in the treatment of lupus is not just to hide the symptoms, but to try to correct the error in the body’s immune memory. Inflammation control, especially in cases with kidney involvement, is the most critical factor that determines the patient’s quality of life.”
Types of Stem Cells Used in Lupus Treatment
Stem cells used in lupus management are evaluated in two main categories based on the patient’s clinical picture and the targeted outcome.
The table below shows the main differences between the application and mechanism of action of these two methods:
Mesenchymal Stem Cells (MSCs)
Mesenchymal stem cells can be used safely without the risk of rejection by the body, thanks to their low immunogenic properties.
These cells exert a rapid anti-inflammatory effect on chronic joint pain and skin lesions caused by lupus, while forming a protective shield for organ functions.
Due to its high safety profile, it is the most preferred cell type in the management of lupus-related tissue damage today.
Hematopoietic Stem Cell Transplantation (HSKN)
HSCN is a more radical method in which the existing immune system is reset with chemotherapy and then the system is rebuilt with new stem cells.
It is usually considered as a last resort in very severe cases with life-threatening organ involvement that is resistant to standard treatments.
The risks of the method make less invasive mesenchymal stem cell therapies one step ahead in clinical research.
Case Analysis (Anonymized): A 29-year-old female patient diagnosed with lupus-related nephritis (kidney involvement) and whose protein leakage could not be controlled underwent a 3-session mesenchymal stem cell cure. In the analyzes performed 4 months after the treatment, it was determined that protein loss in the urine decreased by 45% and the patient experienced a significant relief in joint pain.
Who is Stem Cell Therapy Applied to?
The stem cell approach in lupus treatment is a selective medical method that comes into play when standard protocols are insufficient or when the patient’s quality of life is severely reduced.
Depending on the course of the disease, a personalized evaluation process is initiated for each patient who wants to control the overactivity of the immune system and limit organ damage.
Suitable Candidates for Treatment and Evaluation Criteria
When determining candidates for stem cell application, the stage of the disease and the sites of involvement in the body are meticulously examined.
Generally, individuals who meet the following criteria are included in the scope of treatment:
Active Inflammation: Patients in the active period with high sedimentation and CRP values in blood tests.
Organ Involvement: Cases showing the onset of kidney (lupus nephritis) or nervous system involvement, in particular.
Medication Side Effects: Individuals with low tolerance for side effects of high-dose cortisone or immunosuppressive medications.
Stem Cell Application in Resistant Lupus Cases
In “resistant” cases whose flares cannot be stopped despite traditional treatments, stem cells play a critical role as an “immunoregulator”.
At this stage, the aim is not only to alleviate the symptoms; It is to block faulty signaling pathways at the cellular level that cause the immune system to attack its own tissues.
This biological stabilization provided in resistant cases may allow the dose of heavy drugs used by the patient to be gradually reduced.
According to Assoc. Prof. Dr. Erdinç Özek: “The biggest risk in multi-system diseases such as lupus is irreversible damage to the organs. Stem cell therapy is one of the most powerful clinical options to break this chain of damage and remind the body of its own repair mechanisms, especially in resistant cases.”
How is Stem Cell Therapy Applied?
Stem cell application in lupus disease is carried out in clinical settings with modern medical infrastructure, with full compliance with sterilization protocols.
The treatment process consists of certain stages that will allow the cells to integrate into the body in the most efficient way.
Application Methods and Technical Protocols
The transfer of cells is done by professional methods determined according to the clinical needs of the patient:
Intravenous (Intravenous Access) Injection: It is the most common method; The cells settle in areas of inflammation by performing a systemic scan through the bloodstream.
Local Application: If there is a focused problem in a specific area due to lupus (e.g., severe joint damage or resistant skin lesions), supportive injections can be planned directly to that area.
Dosage Planning: Based on the patient’s weight and disease severity, the number of viable cells per milliliter is precisely calculated.
Post-Treatment Follow-up and Follow-up Process
After the application is completed, a comprehensive follow-up program is initiated to observe the patient’s biological responses.
Here are the key follow-up steps used to monitor the healing process:
First 24 Hours: Monitoring vital signs and the first reactions to cells.
Periodic Blood Analysis: Measurement of changes in autoantibody (ANA, Anti-dsDNA) levels in the 1st, 3rd and 6th months following treatment.
Functional Tests: Preparation of recovery reports for organs with involvement (kidney function, urinalysis, etc.).
Case Study (Anonymized): Mesenchymal stem cell application was preferred in a 34-year-old patient who had been followed up with SLE for 10 years and had limited movement due to intense joint pain. In the 2nd month after treatment, a 70% decrease was observed in the duration of morning stiffness, and in the 6th month, kidney values (creatinine and protein leakage) decreased to normal limits.
Advantages of Stem Cell Therapy and Clinical Outcomes
Stem cell therapy not only temporarily relieves symptoms but also provides long-term clinical gains by targeting the underlying immune dysregulation of the disease in Lupus management.
Unlike traditional treatments, its biggest advantage is that it triggers a systemic healing process by activating the body’s natural repair mechanisms.
Organ Damage Prevention and Inflammation Control
The biggest risk in lupus is that uncontrolled inflammation forms permanent scar tissue in vital organs such as the kidneys, heart and lungs.
Thanks to their “anti-fibrotic” properties, stem cells help prevent this permanent hardening that may develop in organs, while suppressing existing inflammation with cellular signals.
Thus, the functional capacity of the organs is preserved and the risk of organ failure, which is the most feared complication of the disease, is minimized.
Clinical Studies and Success Rates
Many clinical studies in the international medical literature prove that mesenchymal stem cells significantly reduce the disease activity index (SLEDAI) in Lupus patients.
Studies have reported that the amount of steroid (cortisone) use and long-term remission (well-being) are achieved after stem cell application, especially in resistant cases.
These studies demonstrate with scientific data that stem cells suppress autoantibody production by “training” T and B cells in the immune system.
Frequently Asked Questions
Does stem cell therapy cure Lupus completely?
Lupus is a chronic disease and the concept of “complete recovery” in the medical world does not yet apply to every patient; However, stem cells are one of the most effective methods in putting the disease into a silent phase for a long time (remission) and reducing drug dependence.
Is pain or pain felt during the treatment?
The application is usually a painless procedure as it takes place in the form of a standard serum insertion (IV injection). The patient can maintain daily comfort during and after the procedure.
When do the effects of the treatment begin to be seen?
It is a biological process for cells to regulate the immune system. Generally, the first clinical effects (increase in energy, reduction in joint pain) begin within 4-6 weeks, and the improvement in organ function becomes evident from the 3rd month.
Is stem cell therapy safe?
Mesenchymal stem cells, in particular, are cellular products that can be safely administered without the risk of tissue rejection or allergic reactions, thanks to their low immunogenic structure.
According to Assoc. Prof. Dr. Erdinç Özek: “Our most important goal in lupus patients is to dilute the exacerbation periods and protect the patient’s organs. Stem cell therapy offers us a biological key to this goal by sending a ‘stop making mistakes’ message to the immune system.”
Case Study (Anonymized): A 31-year-old patient who experienced severe skin rashes and impaired kidney function due to systemic Lupus underwent a mesenchymal stem cell protocol. It has been clinically reported that skin lesions regressed by 80% and renal filtration rate (GFR) returned to normal at 5 months of treatment.
Resource and Expert Knowledge
This content has been prepared under the scientific supervision of Assoc. Prof. Dr. Erdinç Özek, known for his academic studies and clinical achievements in the field of regenerative medicine and cellular therapy. Assoc. Prof. Dr. Erdinç Özek is one of the competent names in this field in Turkey, who develops the most appropriate cellular therapy strategies by analyzing the patient’s biological data in Lupus and other complex immune system diseases.
